LENSAR Inc
$ 6.04
2.03%
14 Apr - close price
- Market Cap 71,606,000 USD
- Current Price $ 6.04
- High / Low $ 6.15 / 5.90
- Stock P/E N/A
- Book Value -2.17
- EPS -2.87
- Next Earning Report 2026-05-14
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.22 %
- ROE -10.69 %
- 52 Week High 14.31
- 52 Week Low 5.33
About
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.
Analyst Target Price
$8.50
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-31 | 2025-12-31 | 2025-11-06 | 2025-08-07 | 2025-05-07 | 2025-03-03 | 2024-11-07 | 2024-08-08 | 2024-05-09 | 2024-03-04 | 2023-11-09 | 2023-08-09 |
| Reported EPS | -0.1208 | -0.1078 | -0.1098 | -0.15 | -0.0639 | -0.0981 | -0.13 | -0.79 | -0.19 | -0.35 | -0.23 | -0.81 |
| Estimated EPS | None | -0.1 | -0.0482 | -0.07 | -0.155 | -0.18 | -0.29 | -0.29 | -0.28 | -0.22 | -0.34 | -0.35 |
| Surprise | 0 | -0.0078 | -0.0616 | -0.08 | 0.0911 | 0.0819 | 0.16 | -0.5 | 0.09 | -0.13 | 0.11 | -0.46 |
| Surprise Percentage | None% | -7.8% | -127.8008% | -114.2857% | 58.7742% | 45.5% | 55.1724% | -172.4138% | 32.1429% | -59.0909% | 32.3529% | -131.4286% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-14 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: LNSR
2026-04-14 14:41:02
This article reports that the price target for LENSAR (LNSR) has been decreased by 16.67%, bringing it down to $12.75. No additional details regarding the reason for this target change are provided in the snippet.
2026-04-11 19:40:25
The article reports that the price target for LENSAR (LNSR) has been reduced by 32.00%, bringing it down to $8.67. This indicates a significant downward revision in the expected value of the company's stock by analysts.
2026-04-10 07:10:05
This article reports that the price target for LENSAR (LNSR) has been decreased by 32.00% to 8.67. No further details or rationale for this change are provided in the snippet.
2026-04-09 11:39:36
BTIG has upgraded LENSAR, Inc. (LNSR) to a Buy rating on March 17, 2026, without disclosing a specific price target. This upgrade is significant for the thinly covered small-cap company, though the stock has seen a -19.45% decline since the report. Meyka AI assigns LNSR a grade of B+, considering various market factors beyond just analyst ratings.
2026-04-06 02:39:25
This Yahoo Finance page provides comprehensive information on LENSAR, Inc. (LNSR), a commercial-stage medical device company specializing in laser systems for cataract treatment. It includes real-time stock price data, historical performance, key financial metrics, analyst ratings, and a company overview. The article highlights LNSR's products like the LENSAR Laser System and ALLY Robotic Cataract Laser System, and offers comparative data with other medical device companies.
2026-04-04 19:40:13
This article provides an AI-generated analysis of Lensar Inc. (NASDAQ: LNSR), highlighting near-term strong sentiment potentially challenging persistent mid and long-term weakness. It identifies elevated downside risk and offers three distinct institutional trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, complete with entry zones, target prices, and stop losses. The analysis also includes multi-timeframe signal analysis with support and resistance levels.
